Shaheen Majeed, President Worldwide, Sabinsa, tells how the company is navigating uncertain times, the importance of IP/innovation, and plans for the future.
According to Dr. Richard Kingston, FDA's Adverse Events Reporting contains gaps in context, which fail to expose consumers to the full scope of information.